Table 3.
Complications of patients infected with COVID-19.
| Variables | Total (n = 388) | Normotension (n = 313) | Hypertension (n = 75) | p value |
|---|---|---|---|---|
| Time of hospitalization, mean (SD), d | 16.4 ± 7.3 | 15.9 ± 7.1 | 18.7 ± 8.0 | < 0.001 |
| Time from symptom onset to hospital admission, mean (SD) | 5.4 ± 3.6 | 5.3 ± 3.6 | 5.8 ± 3.8 | 0.399 |
| Severity of illness (n, %) | ||||
| Severe | 56 (11.4) | 38 (12.1) | 57 (76) | < 0.001 |
| Mild | 332 (85.3) | 275 (87.9) | 18 (24) | |
| Complications (n, %) | ||||
| Drug-induced hepatitis | 32 (8.2) | 26 (8.3) | 6 (8.0) | 0.931 |
| Electrolyte disorder | 48 (12.3) | 35 (11.2) | 13 (17.3) | ≤ 0.05 |
| Hypoproteinemia | 28 (7.2) | 15 (4.8) | 13 (17.3) | < 0.001 |
| Anemia | 20 (5.1) | 15 (4.8) | 5 (6.7) | 0.560 |
| Pneumonia | 22 (5.7) | 16 (5.1) | 6 (8.0) | 0.401 |
| Arrhythmia | 7 (1.8) | 6 (1.9) | 1 (1.3) | 0.998 |
| Leukopenia | 8 (2.1) | 8 (2.6) | 0 (0) | 0.363 |
| Acute respiratory distress syndrome | 14 (3.6) | 8 (2.6) | 6 (8.0) | ≤ 0.05 |